<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01008735</url>
  </required_header>
  <id_info>
    <org_study_id>FertHD</org_study_id>
    <nct_id>NCT01008735</nct_id>
  </id_info>
  <brief_title>Gonadal Toxicity in Women With Hodgkin Lymphoma</brief_title>
  <acronym>FertHD</acronym>
  <official_title>Observational Retrospective Study to Evaluate the Incidence of the Gonadal Toxicity in Women of Reproductive Age With Hodgkin Lymphoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gruppo Italiano Studio Linfomi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gruppo Italiano Studio Linfomi</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Gruppo Italiano Studio Linfomi has been collecting data on patients with Hodgkin Lymphoma
      (HL) since 1988. This archive represents a homogeneous series of consecutive patients with
      HL. The very long follow up and the availability of clinical and treatment data make it
      feasible to perform a study on the gonadal toxicity related to treatment for HL.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2009</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of gonadal toxicity in terms of irreversible amenorrhea and infertility, in women of reproductive age with Hodgkin lymphoma treated with chemotherapy.</measure>
    <time_frame>from end of treatment until date of last contact/visit</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>role of a prophylactic treatment with oral contraceptives and GnRH analogs in preventing gonadal damage</measure>
    <time_frame>from end of treatment until date of last contact/visit</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Hodgkin Lymphoma</condition>
  <arm_group>
    <arm_group_label>women with hodgkin lymphoma treated with chemotherapy</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Female patients with Hodgkin lymphoma diagnosed until 2007 in Italy will be considered
        eligible for this study. Cases will be identified from the archives of GISL.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female patients in complete remission after chemotherapy for Hodgkin lymphoma

          -  Age â‰¥ 18 e &lt; 40 years

          -  Previous regular menstrual cycle

          -  No previous or concomitant gynecological diseases affecting reproducing function

          -  No other chemo-radiotherapy for other neoplasm

          -  Written informed consent

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francesco Angrilli, MD</last_name>
    <role>Study Chair</role>
    <affiliation>GISL</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Simona Falorio, MD</last_name>
    <role>Study Chair</role>
    <affiliation>GISL</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Massimo Federico, MD</last_name>
    <role>Study Chair</role>
    <affiliation>GISL</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Antonella Montanini, BSc, PhD</last_name>
    <phone>+39 059 4223284</phone>
    <email>amontanini@unimore.it\</email>
  </overall_contact>
  <location>
    <facility>
      <name>Gruppo Italiano Studio Linfomi</name>
      <address>
        <city>Modena</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonella Montanini, BSc, PhD</last_name>
      <phone>+39 059 4223284</phone>
      <email>amontanini@unimore.it</email>
    </contact>
    <investigator>
      <last_name>Massimo Federico, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2009</study_first_submitted>
  <study_first_submitted_qc>November 5, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 6, 2009</study_first_posted>
  <last_update_submitted>November 11, 2009</last_update_submitted>
  <last_update_submitted_qc>November 11, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 13, 2009</last_update_posted>
  <responsible_party>
    <name_title>Massimo Federico</name_title>
    <organization>Gruppo Italiano Studio Linfomi</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphoma</mesh_term>
    <mesh_term>Hodgkin Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

